☰

Christopher Lowrey - Publications

Affiliations: 
Dartmouth College, Hanover, NH, United States 
Area:
Pharmacology, Molecular Biology, Biochemistry, Pathology
Tree Info Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Hahn CK, Lowrey CH. Induction of fetal hemoglobin through enhanced translation efficiency of γ-globin mRNA. Blood. 124: 2730-4. PMID 25170120 DOI: 10.1182/Blood-2014-03-564302  0.721
2014 Schaeffer EK, West RJ, Conine SJ, Lowrey CH. Multiple physical stresses induce γ-globin gene expression and fetal hemoglobin production in erythroid cells. Blood Cells, Molecules & Diseases. 52: 214-24. PMID 24314748 DOI: 10.1016/j.bcmd.2013.10.007  0.452
2013 Hahn CK, Lowrey CH. Eukaryotic initiation factor 2α phosphorylation mediates fetal hemoglobin induction through a post-transcriptional mechanism. Blood. 122: 477-85. PMID 23690448 DOI: 10.1182/Blood-2013-03-491043  0.767
2013 Macari ER, Schaeffer EK, West RJ, Lowrey CH. Simvastatin and t-butylhydroquinone suppress KLF1 and BCL11A gene expression and additively increase fetal hemoglobin in primary human erythroid cells. Blood. 121: 830-9. PMID 23223429 DOI: 10.1182/Blood-2012-07-443986  0.754
2011 Macari ER, Lowrey CH. Induction of human fetal hemoglobin via the NRF2 antioxidant response signaling pathway. Blood. 117: 5987-97. PMID 21464371 DOI: 10.1182/Blood-2010-10-314096  0.745
2011 Bates DJP, Lowrey C, Eastman A. Abstract 2138: Vinblastine acutely sensitizes hematopoietic cancers to Bcl-2 targeting drugs Cancer Research. 71: 2138-2138. DOI: 10.1158/1538-7445.Am2011-2138  0.335
2010 Bates DJP, Lowrey C, Eastman A. Abstract 2993: Vinblastine induces very rapid apoptosis in chronic lymphocytic leukemia and mantle cell lymphoma Cancer Research. 70: 2993-2993. DOI: 10.1158/1538-7445.Am10-2993  0.332
2009 Hsu M, Richardson CA, Olivier E, Qiu C, Bouhassira EE, Lowrey CH, Fiering S. Complex developmental patterns of histone modifications associated with the human beta-globin switch in primary cells. Experimental Hematology. 37: 799-806.e4. PMID 19460472 DOI: 10.1016/J.Exphem.2009.04.006  0.412
2009 Lathrop MJ, Hsu M, Richardson CA, Olivier EN, Qiu C, Bouhassira EE, Fiering S, Lowrey CH. Developmentally regulated extended domains of DNA hypomethylation encompass highly transcribed genes of the human beta-globin locus. Experimental Hematology. 37: 807-813.e2. PMID 19460471 DOI: 10.1016/J.Exphem.2009.04.005  0.393
2008 Mabaera R, West RJ, Conine SJ, Macari ER, Boyd CD, Engman CA, Lowrey CH. A cell stress signaling model of fetal hemoglobin induction: what doesn't kill red blood cells may make them stronger. Experimental Hematology. 36: 1057-72. PMID 18718415 DOI: 10.1016/J.Exphem.2008.06.014  0.713
2008 Mabaera R, Greene MR, Richardson CA, Conine SJ, Kozul CD, Lowrey CH. Neither DNA hypomethylation nor changes in the kinetics of erythroid differentiation explain 5-azacytidine's ability to induce human fetal hemoglobin. Blood. 111: 411-20. PMID 17916742 DOI: 10.1182/blood-2007-06-093948  0.363
2007 Mabaera R, Richardson CA, Johnson K, Hsu M, Fiering S, Lowrey CH. Developmental- and differentiation-specific patterns of human gamma- and beta-globin promoter DNA methylation. Blood. 110: 1343-52. PMID 17456718 DOI: 10.1182/blood-2007-01-068635  0.38
2007 Hsu M, Mabaera R, Lowrey CH, Martin DI, Fiering S. CpG hypomethylation in a large domain encompassing the embryonic beta-like globin genes in primitive erythrocytes. Molecular and Cellular Biology. 27: 5047-54. PMID 17452448 DOI: 10.1128/Mcb.02234-06  0.4
2007 Layon ME, Ackley CJ, West RJ, Lowrey CH. Expression of GATA-1 in a non-hematopoietic cell line induces beta-globin locus control region chromatin structure remodeling and an erythroid pattern of gene expression. Journal of Molecular Biology. 366: 737-44. PMID 17196618 DOI: 10.1016/J.Jmb.2006.11.094  0.762
2007 West R, Venkatesan P, Lowrey C. 75Targeting GATA-1 to binding sites in nuclear chromatin Blood Cells Molecules and Diseases. 38: 156. DOI: 10.1016/J.Bcmd.2006.10.086  0.312
2006 Ermentrout RM, Layon ME, Ackley CJ, Venkatesan P, Lowrey CH. The effects of lead and cadmium on GATA-1 regulated erythroid gene expression. Blood Cells, Molecules & Diseases. 37: 164-72. PMID 17055757 DOI: 10.1016/J.Bcmd.2006.08.006  0.728
2006 Mankidy R, Faller DV, Mabaera R, Lowrey CH, Boosalis MS, White GL, Castaneda SA, Perrine SP. Short-chain fatty acids induce gamma-globin gene expression by displacement of a HDAC3-NCoR repressor complex. Blood. 108: 3179-86. PMID 16849648 DOI: 10.1182/Blood-2005-12-010934  0.454
2006 Lowrey C. Another piece of the globin-switching puzzle Blood. 107: 1744-1744. DOI: 10.1182/Blood-2005-12-4896  0.427
2004 Nemeth MJ, Lowrey CH. An Erythroid-Specific Chromatin Opening Element Increases β-Globin Gene Expression from Integrated Retroviral Gene Transfer Vectors. Gene Therapy & Molecular Biology. 8: 475-486. PMID 16670777  0.713
2002 Miller J, Horner A, Stacy T, Lowrey C, Lian JB, Stein G, Nuckolls GH, Speck NA. The core-binding factor beta subunit is required for bone formation and hematopoietic maturation. Nature Genetics. 32: 645-9. PMID 12434155 DOI: 10.1038/Ng1049  0.331
2002 Kitareewan S, Pitha-Rowe I, Sekula D, Lowrey CH, Nemeth MJ, Golub TR, Freemantle SJ, Dmitrovsky E. UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America. 99: 3806-11. PMID 11891284 DOI: 10.1073/Pnas.052011299  0.631
2001 Nemeth MJ, Bodine DM, Garrett LJ, Lowrey CH. An erythroid-specific chromatin opening element reorganizes beta-globin promoter chromatin structure and augments gene expression. Blood Cells, Molecules & Diseases. 27: 767-80. PMID 11778661 DOI: 10.1006/Bcmd.2001.0448  0.734
2000 McInerney JM, Nemeth MJ, Lowrey CH. Erythropoiesis: Review Article: Slow and Steady Wins The Race? Progress in the Development of Vectors for Gene Therapy of beta-Thalassemia and Sickle Cell Disease. Hematology (Amsterdam, Netherlands). 4: 437-455. PMID 11399586  0.686
1999 Mcinerney JM, Nemeth MJ, Lowrey CH. Slow and Steady Wins The Race? Progress in the Development of Vectors for Gene Therapy of β-Thalassemia and Sickle Cell Disease. Hematology (Amsterdam, Netherlands). 4: 437-55. PMID 27426849 DOI: 10.1080/10245332.1999.11746470  0.662
1999 Iler N, Goodwin AJ, McInerney J, Nemeth MJ, Pomerantz O, Layon ME, Lowrey CH. Targeted remodeling of human beta-globin promoter chromatin structure produces increased expression and decreased silencing. Blood Cells, Molecules & Diseases. 25: 47-60. PMID 10349513 DOI: 10.1006/Bcmd.1999.0226  0.716
Show low-probability matches.